Biosimilars Mark Milestone In Europe With Regulators' Nod
European regulators on Thursday recommended approval of biosimilar drugs from Hospira Inc. and Celltrion Inc. that are more complex than any others previously cleared for sale, a milestone that heralds possible...To view the full article, register now.
Already a subscriber? Click here to view full article